Senior insider sale
Chief Executive Officer at NEUROCRINE BIOSCIENCES INC — senior position signals high conviction
$14.81M
115.94K shares
What this filing means
GORMAN KEVIN CHARLES plans to sell 115.94K shares of NEUROCRINE BIOSCIENCES INC valued at approximately $14.81M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/7/2025ACC: 0001950047-25-005520
DirectorOfficer· Chief Executive Officer
Since Feb 2019
115.94K
Shares to sell
$14.81M
Approx. market value
106.32K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
8/7/2025
106.32KTotal acquired106.32K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/7/2025 | Exercise of Stock Options Cash | 106.32K | — |
| Total | 106.32K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
9.61K
Market value
$1.16M
5/27/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
106.32K
Market value
$13.65M
8/7/2025
Total
Units
115.94K
Value
$14.81M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/27/2025 | 9.61K | $1.16M | — | Completed |
| Planned — Approximate Date | ||||
8/7/2025 | 106.32K | $13.65M | NASDAQ | Planned |
| Total | 115.94K | $14.81M | ||